SCHEMBL8300345

SCHEMBL8300345

Cc1cc(N(C)C)nc2c1NC(=O)c1cccnc1N2C1CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
LMNA P02545 1/20 0.69
POLB P06746 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
MAPK1 P28482 1/20 0.69
ADORA2A P29274 1/20 0.69
ADORA1 P30542 1/20 0.69
PDE3A Q14432 1/20 0.69
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
IDH1 O75874 1/20 0.33
CYP3A4 P08684 1/20 0.33
TNKS2 Q9H2K2 1/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
MCL1 Q07820 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8889186 0.89 ALDH1A1 (0.63) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8299453 0.87 ALDH1A1 (0.75) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8887731 0.86 ALDH1A1 (0.73) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8887408 0.85 ALDH1A1 (0.72) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8889576 0.85 ALDH1A1 (0.72) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8304966 0.85 ALDH1A1 (0.72) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8299602 0.83 ALDH1A1 (0.69) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8888702 0.82 ALDH1A1 (0.68) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL8301125 0.82 ALDH1A1 (0.46) ALDH1A1LMNAPOLBADORA3MAPK1
Nevirapine SCHEMBL3318 0.82 ALDH1A1 (1.00) ALDH1A1LMNAPOLBADORA3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP claimed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US claimed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed